Heart Attack Diagnostics Market Size, Trends, Industry 2031

Heart Attack Diagnostics Market Size, Trends, Industry 2031

Segments - Heart Attack Diagnostics Market by Test Type (Electrocardiogram, Blood Tests [Troponin and Creatine Kinase MB Isoenzyme], Computerized Cardiac Tomography, Angiogram, and Echocardiogram), End-user (Hospitals, Diagnostics Centers, Ambulatory Surgical Centers, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023– 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-672 | 4.2 Rating | 81 Reviews | 198 Pages | Format : PDF Excel PPT

Report Description


The global heart attack diagnostics market size was USD 12.40 Bn in 2022 and is likely to reach USD 23.90 Bn by 2031, expanding at a CAGR of 7.1% during 2023–2031. The market growth is attributed to the rising prevalence of heart disease cases, increasing research & government initiatives, and increasing health expenditure.

Heart attack, also known as Myocardial Infarction (MI), is a type of heart disease that generally occurred when the heart stops its normal function of circulating blood and oxygen. Without proper medications or medical guidelines, patients with heart diseases have a high risk of heart attack or cardiac arrest which can cause death.

Global Heart Attack Diagnostics Market Outlook

The pathophysiology of heart attack includes tissue necrosis of the myocardium layer of the heart. Bad diet, obesity, high cholesterol, smoking, and hypertension are some of the concerning factors that increase the probability of heart disease in 1 out of 5 people worldwide. As a result, technical improvements and diagnostic treatments are improving and developing.

The COVID-19 pandemic has moderately increased the demand for the heart attack diagnostics market. There is an estimated increase in the occurrence of heart disease due to coronavirus contact. Those prone to heart illnesses have a high probability of death if the diagnosis of the virus is delayed. Some early symptoms of COVID-19 are associated with the heart such as chest pain, fatigue, and nausea.

Heart Attack Diagnostics Market Dynamics

The global heart attack diagnostics market report has up-to-date insights that help in formulating a strategic roadmap about the estimated market scenario and performance from 2023 to 2031.

Global Heart Attack Diagnostics Market Dynamics

Drivers

The rising incidence of coronary artery disease (CAD) and heart stroke, the growing number of aging populaces, and inactive lifestyles need assistance. This results in increased demand for heart attack diagnostics. Increasing tobacco and & alcohol consumption, rising prevalence of obesity and high blood pressure & diabetes, and improper diet are expected to boost the market expansion during the forecast period.

Restraints

The high cost of heart attack diagnostics therapy is acting as a major expected factor to hamper the market growth in the coming years. In case of a heart attack, patients often require immediate support such as ambulance services, diagnostic tests for heart attack, and hospitalization. The costs included in these support services are often high. Cardiologist appointments, medication, and testing are estimated to be some of the expensive processes that impact restraining the market.

Opportunities

Rising research collaborations to develop advanced technology and increasing government initiatives for the development of healthcare infrastructure are projected to create lucrative opportunities for market expansion during the forecast period.

Scope of Heart Attack Diagnostics Market Report

The global heart attack diagnostics market research report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Heart Attack Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2020–2021

Forecast Period

2023–2031

Segmentation

Test Type (Electrocardiogram, Blood Tests [Troponin and Creatine Kinase MB Isoenzyme], Computerized Cardiac Tomography, Angiogram, and Echocardiogram) and End-user (Hospitals, Diagnostics Centers, Ambulatory Surgical Centers, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

Siemens Healthcare AG; Midmark Corporation; Koninklijke Phillips N.V.; Schiller AG; Hitachi, Ltd.; F. Hoffmann-La Roche Ltd.; Abbott; Bio-Rad Laboratories, Inc.; Beckman Coulter, Inc.; and CANON MEDICAL SYSTEMS CORPORATION

Heart Attack Diagnostics Market Segment Insights

Based on test types, the heart attack diagnostics market is divided into electrocardiogram, blood tests, computerized cardiac tomography, angiogram, and echocardiogram. The blood test segment is further divided into troponin and creatine kinase MB isoenzyme (CK-MB).

The blood test segment is expected to expand at a significant growth rate during the projection period, as the troponin blood test is widely used for the detection of heart disease across the globe.

Global Heart Attack Diagnostics Market Test Type

On the basis of end-user, the global heart attack diagnostics market is segregated into hospitals, diagnostics centers, ambulatory surgical centers, and others. The hospital segment is projected to register a considerable CAGR during the forecast period, attributed to the estimated increased number of hospitals in the regions globally.

Among the hospitals globally, US-based hospitals alone are estimated to have carried out about 8,00,000 cardiac operations. This factor is estimated to have a key share in the expansion of the market.

In terms of region, the global heart attack diagnostics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, owing to the rising awareness and health expenditure on heart disease, desk-bound lifestyle, and adoption of advanced technology in the region.

Global Heart Attack Diagnostics Market Region

Segments

The global heart attack diagnostics market has been segmented on the basis of

Test Type

  • Electrocardiogram
  • Blood Tests
    • Troponin
    • Creatine Kinase MB Isoenzyme
  • Computerized Cardiac Tomography
  • Angiogram
  • Echocardiogram

End-user

  • Hospitals
  • Diagnostics Centers
  • Ambulatory Surgical Centers
  • Others

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

Competitive Landscape

Key players competing in the global heart attack diagnostic market are Siemens Healthcare AG; Midmark Corporation; Koninklijke Phillips N.V.; Schiller AG; Hitachi, Ltd.; F. Hoffmann-La Roche Ltd.; Abbott; Bio-Rad Laboratories, Inc.; Beckman Coulter, Inc.; and CANON MEDICAL SYSTEMS CORPORATION.

These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide. For instance,

  • In April 2021, F. Hoffmann-La Roche Ltd. launched a series of five innovations for two main cardiac biomarkers using the Elecsys technology, which is a highly sensitive cardiac troponin and N-terminal pro-brain natriuretic peptide test.
  • In July 2021, CANON MEDICAL SYSTEMS CORPORATION partnered with Cleerly, Inc. for the adoption of cardiac CT, which is projected to bring key advancements in the heart disease diagnostic industry.
Global Heart Attack Diagnostics Market Share

Frequently Asked Questions

The heart attack diagnostic key market players are Siemens Healthcare AG; Midmark Corporation; Koninklijke Phillips N.V.; Schiller AG; Hitachi, Ltd.; F. Hoffmann-La Roche Ltd.; Abbott; Bio-Rad Laboratories, Inc.; Beckman Coulter, Inc.; and CANON MEDICAL SYSTEMS CORPORATION.

For regional analysis, North America is projected to dominate the market during the forecast period.

The opportunities in the heart attack diagnostic market include increasing government initiatives for the development of healthcare infrastructure.

The key driver for the heart attack diagnostic market is the rising incidence of CAD and heart stroke and the need for diagnostic assistance.

The global heart attack diagnostics market size was USD 12.40 Bn in 2022 and is likely to reach USD 23.90 Bn by 2031, expanding at a CAGR of 7.1% during 2023–2031.

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Heart Attack Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Heart Attack Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Heart Attack Diagnostics Market - Supply Chain
  4.5. Global Heart Attack Diagnostics Market Forecast
     4.5.1. Heart Attack Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Heart Attack Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Heart Attack Diagnostics Market Absolute $ Opportunity
5. Global Heart Attack Diagnostics Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Heart Attack Diagnostics Market Size and Volume Forecast by End Users
     5.3.1. Hospitals
     5.3.2. Diagnostics Centers
     5.3.3. Ambulatory Surgical Centers
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Heart Attack Diagnostics Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Heart Attack Diagnostics Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Heart Attack Diagnostics Demand Share Forecast, 2019-2026
7. North America Heart Attack Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Heart Attack Diagnostics Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Heart Attack Diagnostics Market Size and Volume Forecast by End Users
     7.4.1. Hospitals
     7.4.2. Diagnostics Centers
     7.4.3. Ambulatory Surgical Centers
     7.4.4. Others
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Heart Attack Diagnostics Demand Share Forecast, 2019-2026
8. Latin America Heart Attack Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Heart Attack Diagnostics Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Heart Attack Diagnostics Market Size and Volume Forecast by End Users
     8.4.1. Hospitals
     8.4.2. Diagnostics Centers
     8.4.3. Ambulatory Surgical Centers
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Heart Attack Diagnostics Demand Share Forecast, 2019-2026
9. Europe Heart Attack Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Heart Attack Diagnostics Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Heart Attack Diagnostics Market Size and Volume Forecast by End Users
     9.4.1. Hospitals
     9.4.2. Diagnostics Centers
     9.4.3. Ambulatory Surgical Centers
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Heart Attack Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific Heart Attack Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Heart Attack Diagnostics Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Heart Attack Diagnostics Market Size and Volume Forecast by End Users
     10.4.1. Hospitals
     10.4.2. Diagnostics Centers
     10.4.3. Ambulatory Surgical Centers
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Heart Attack Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa Heart Attack Diagnostics Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Heart Attack Diagnostics Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Heart Attack Diagnostics Market Size and Volume Forecast by End Users
     11.4.1. Hospitals
     11.4.2. Diagnostics Centers
     11.4.3. Ambulatory Surgical Centers
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Heart Attack Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Heart Attack Diagnostics Market: Market Share Analysis
  12.2. Heart Attack Diagnostics Distributors and Customers
  12.3. Heart Attack Diagnostics Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Siemens Healthcare AG
     12.4.2. Midmark Corporation
     12.4.3. Koninklijke Phillips N.V.
     12.4.4. Schiller AG
     12.4.5. Hitachi, Ltd.
     12.4.6. F. Hoffmann-La Roche Ltd.
     12.4.7. Abbott
     12.4.8. Bio-Rad Laboratories, Inc.
     12.4.9. Beckman Coulter, Inc.
     12.4.10. AstraZeneca

Methodology

Our Clients

Deloitte
Nestle SA
General Electric
Siemens Healthcare
FedEx Logistics
sinopec
Pfizer
General Mills